Low-dose steroids for septic shock and severe sepsis: the use of Bayesian statistics to resolve clinical trial controversies (Q37829657)

24 August 2017

1 reference

title

Low-dose steroids for septic shock and severe sepsis: the use of Bayesian statistics to resolve clinical trial controversies (English)

1 reference

24 August 2017

0 references

0 references

1 reference

Andre C Kalil

1

1 reference

PubMed ID

21243334

24 August 2017

Junfeng Sun

series ordinal

2

1 reference

24 August 2017

18 January 2011

1 reference

24 August 2017

Intensive Care Medicine

1 reference

24 August 2017

37

1 reference

24 August 2017

3

1 reference

24 August 2017

420-429

1 reference

https://scigraph.springernature.com/pub.10.1007/s00134-010-2121-0

24 August 2017

0 references

cites work

Effect of high-dose glucocorticoid therapy on mortality in patients with clinical signs of systemic sepsis

1 reference

https://api.crossref.org/works/10.1007%2FS00134-010-2121-0

Corticosteroid treatment for sepsis: a critical appraisal and meta-analysis of the literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-010-2121-0

Reversal of late septic shock with supraphysiologic doses of hydrocortisone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-010-2121-0

Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-010-2121-0

Physiological-dose steroid therapy in sepsis [ISRCTN36253388]

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-010-2121-0

Low-dose hydrocortisone improves shock reversal and reduces cytokine levels in early hyperdynamic septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-010-2121-0

Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-010-2121-0

Hydrocortisone therapy for patients with septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-010-2121-0

The effects of steroids during sepsis depend on dose and severity of illness: an updated meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-010-2121-0

Corticosteroids in the treatment of severe sepsis and septic shock in adults: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-010-2121-0

Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statements from an international task force by the American College of Critical Care Medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-010-2121-0

Efficacy and safety of recombinant human activated protein C for severe sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-010-2121-0

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-010-2121-0

Why are clinicians not embracing the results from pivotal clinical trials in severe sepsis? A bayesian analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-010-2121-0

How many patients with severe sepsis are needed to confirm the efficacy of drotrecogin alfa activated? A Bayesian design.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-010-2121-0

Methylprednisolone infusion in early severe ARDS: results of a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-010-2121-0

Effect of stress doses of hydrocortisone on S-100B vs. interleukin-8 and polymorphonuclear elastase levels in human septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-010-2121-0

Steroid therapy of septic shock: the decision is in the eye of the beholder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-010-2121-0

Is the cortrosyn test necessary in high basal corticoid patients with septic shock?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-010-2121-0

Risk and the efficacy of antiinflammatory agents: retrospective and confirmatory studies of sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-010-2121-0

Risk of death does not alter the efficacy of hydrocortisone therapy in a mouse E. coli pneumonia model: risk and corticosteroids in sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-010-2121-0

Effectiveness of treatments for severe sepsis: a prospective, multicenter, observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-010-2121-0

The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-010-2121-0

Early blood glucose control and mortality in critically ill patients in Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-010-2121-0

Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-010-2121-0

Administration of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) by intravenous infusion for up to 72 hours can promote the resolution of shock in patients with severe sepsis: results of a randomized, double-blind, p

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-010-2121-0

Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-010-2121-0

Hydrocortisone infusion for severe community-acquired pneumonia: a preliminary randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-010-2121-0

Effects of single dose of dexamethasone on patients with systemic inflammatory response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-010-2121-0

Corticosteroids for septic shock

21 January 2018

1 reference

12 December 2020

Low-dose hydrocortisone did not improve survival in patients with septic shock but reversed shock earlier

1 reference

12 December 2020

Effects of a nitric oxide synthase inhibitor in humans with septic shock

1 reference

12 December 2020

Bayesian methods in health technology assessment: a review

1 reference

12 December 2020

Low-dose hydrocortisone during severe sepsis: effects on microalbuminuria

1 reference

12 December 2020

New recommendations for the use of corticosteroids in sepsis: not so fast!

1 reference

12 December 2020

Statistical aspects of the analysis of data from retrospective studies of disease

1 reference

12 December 2020

Steroids in the treatment of clinical septic shock

1 reference

12 December 2020

The effects of high-dose corticosteroids in patients with septic shock. A prospective, controlled study

1 reference

12 December 2020

Inappropriate sympathetic activation at onset of septic shock: a spectral analysis approach

1 reference

12 December 2020

L-arginine pathway in the sepsis syndrome.

1 reference

12 December 2020

Corticosteroids for septic shock

1 reference

12 December 2020

Corticosteroid therapy for severe sepsis and septic shock

1 reference

12 December 2020

10.1007/S00134-010-2121-0

Identifiers

DOI

1 reference

24 August 2017

1 reference

PubMed ID

21243334